Application no. and date | 15795707.7 (espacenet) (Federated) (European Patent Register), 20150519 | Patent/reg. no. and date | DK/EP 3145508, 20230705 | Publication date | 20170329 | Priority no. and date | US 201462000119 P, 20140519 | EP pub. no. and date |
EP 3145508 20170329 | Effective date | | Applicant/owner | Chiesi Farmaceutici S.p.A., Via Palermo, 26/A
43122 Parma, IT | Applicant ref. no. | | Inventor | MOTHERAM, Rajeshwar, 17 Summerfield Boulevard
Dayton, NJ 08810, US, HANLEY, Sr. David C., 86 Whisconier Road
Brookfield, CT 06804, US, TÜRELI, Akif Emre, Industriestrasse 28
66740 Saarlouis, DE, KANTER, Monika, Am Ehrenmal 2
54439 Saarburg, DE | Representative | | Opponent | | IPC Class | A61K 31/4422 (2006.01) , A61K 47/10 (2017.01) , A61K 9/10 (2006.01) , A61K 9/19 (2006.01) , A61K 9/51 (2006.01) | Title | CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF | Int. application no. | US2015031470 | Int. publication no. | WO2015179334 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|